Reliance Industries share price: Reliance Industries acquired Karkinos Healthcare for Rs 375 crore through its subsidiary Reliance Strategic Business Ventures Over the past week, Reliance Industries ...
The acquisition of the oncology platform Karkinos Healthcare by Reliance Industries Limited has added another stack to the Indian conglomerate's diagnostic and digital healthcare ecosystem ...
Reliance Industries Limited has intensified its push into the healthcare sector with the acquisition of Karkinos Healthcare, an oncology platform, through its subsidiary Reliance Strategic Business ...
Reliance Industries has bought the technology-driven oncology platform Karkinos Healthcare for ₹375 crore through Reliance Strategic Business Ventures. The deal consists of ₹10 crore equity ...
RIL said that Karkinos has canceled the existing outstanding 30,075 equity shares held by the erstwhile shareholders of Karkinos in accordance with the approved resolution plan."Post-allotment of ...
Reliance Industries, through its subsidiary RSBVL, has acquired the oncology-focused platform Karkinos for Rs 375 crore. Karkinos provides technology-driven cancer care solutions and aims to offer ...
Reliance Industries (RIL) shares will remain in focus on Monday after the company on Saturday announced the acquisition of technology-led oncology platform Karkinos Healthcare for Rs 375 crore ...
The acquisition strengthens Reliance's healthcare portfolio, focusing on technology-driven cancer detection and treatment solutions Reliance Industries has completed the acquisition of Karkinos ...
RIL initially acquired a minority stake in Karkinos in 2021. The deal, valued at Rs 375 crore, includes the subscription of one crore equity shares worth Rs 10 crore and 36.50 crore optionally fully ...
Mukesh Ambani-led Reliance Industries Limited has acquired healthcare platform Karkinos for Rs 375 crore, the company asserted on December 28. The firm informed in a stock exchange filing that ...
Reliance Industries has successfully acquired Karkinos Healthcare, a technology-focused oncology platform, for Rs 375 crore. The deal has been made by the Reliance Strategic Business Ventures, ...